- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Papers: 13 May 2023 - 19 May 2023
RESEARCH TYPE:
Basic Science
Animal Studies, Molecular/Cellular, Pharmacology/Drug Development
PAIN TYPE:
Inflammation/Inflammatory, Neuropathic Pain
2023 May 12
Eur J Pain
The compound NS5806 attenuates neuropathic pain via inhibiting extracellular signal-regulated kinase (ERK) activation in neuronal somata located at the dorsal root ganglion (DRG) and superficial spinal dorsal horn. NS5806 also reduces the expansion of DRG macrophages and spinal microglia several days after peripheral nerve injury, implying an anti-inflammatory effect.